Atomic AI combines machine learning with structural biology to enable the design of RNA-targeted small molecules and RNA-based therapeutics. Its proprietary R&D platform integrates deep learning foundation models with specialized in-house wet-lab assays to support iterative discovery and refinement. A key component of the platform is ATOM-1™, a large language model trained on chemical mapping data to predict RNA structure and function more accurately.